Corrigendum: A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of 7 day buprenorphine transdermal patch in osteoarthritis patients naïve to potent-opioids (Scandinavian Journal of Pain (2010) 1 (122-141) DOI: 10.1016/j.sjpain.2010.05.035);A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine transdermal patch in osteoarthritis patients naïve to potent opioids

Scandinavian Journal of Pain

Volumn 1, Issue 3, 2010, Pages 122-141

  Breivik, Harald ^a   Ljosaa, Tone Marte ^a   Stengaard Pedersen, Kristian ^b   Persson, Jan ^c   Aro, Hannu ^d   Villumsen, John ^e   Tvinnemose, Dorthe ^f  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF TURKU   (Finland)

^e Cyncron A/S   (Denmark)

^f Norpharma A/S   (Denmark)

Author keywords

Buprenorphine; Chronic pain; Movement related pain; Osteoarthritis; Patients' global impression of change; Placebo; Transdermal patch

Indexed keywords

ALKALINE PHOSPHATASE; BUPRENORPHINE; BUTRANS; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; NORSPAN; PARACETAMOL; PLACEBO; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; APPLICATION SITE DERMATITIS; APPLICATION SITE ECZEMA; APPLICATION SITE ERYTHEMA; APPLICATION SITE IRRITATION; APPLICATION SITE PRURITUS; ARTICLE; CHRONIC PAIN; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; DENMARK; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FINLAND; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL SYMPTOM; HIP OSTEOARTHRITIS; HIP PAIN; HIP RADIOGRAPHY; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; KNEE RADIOGRAPHY; LOCAL SKIN REACTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MOVEMENT (PHYSIOLOGY); MULTICENTER STUDY; NAUSEA; NORWAY; OSTEOARTHRITIS; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLEEP; SLEEP DISORDER; SOMNOLENCE; SWEDEN; TRANSDERMAL PATCH; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VOMITING;

EID: 77955046113     PISSN: 18778860     EISSN: 18778879     Source Type: Journal    
DOI: 10.1016/j.sjpain.2010.10.001     Document Type: Erratum

References (27)

1. (last accessed April 20,2010). http://www.who.int/chp/topics/rheumatic/en.
2. American Geriatric Society (AGS) Panel on pharamcological management of persistent pain in older persons. J Amer Geriatc Soc 2009; 67: 1331-46.
3. 2008 European Guidelines for primary care management of chronic osteoarthritis pain. (last accessed April 29,2010). http://www.eguidelines.co.uk/.
4. The American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 Update. Arthritis & Rheumatism, 2000; 43:1905-15.
5. Kalso E., Edwards J.E., Moore A., McQuay H.J. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004, 112:372-380.
6. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, Schoelles KM. Long-term opioid management for chronic noncancer pain. Cochrane Database of Systematic Reviews 2010, Issue 1. Art.No.: CD006605. DOI: 10.1002/14651858. CD006605.pub2.
7. Peloso P.M., Fortin L., Beaulieu A., Kamin M. Analgesic efficacy and safety of tramadol/acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial. J Rheumatol 2004, 31:2454-2463. Rosenthal N Protocol TRP-CAN-1 Study Group.
8. Kress H.G. Clinical update on the pharmacology, efficacy and safethy of transdermal buprenorphine. Eur J Pain 2009, 13:219-230.
9. Kellgren J.H., Lawrence J.S. Osteo-arthrosis and disk degeneration in an urban population. Ann Rheum Dis 1958, 17:388-397.
10. Declaration of Helsinki. Ethical principles for medical research involving human subjects. World Medical Association Website: http://www.wma.net/e/policy/b3.htm.
11. ICH Topic E6 (R1): Guidelines for good clinical practice: Consolidated Guideline. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Website: http://www.ich.org/LOB/media/MEDIA482.pdf.
12. Bellamy N., Buchnan W.W., Goldsmith C.H., Campbell J., Stitt L.W. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988, 15:1833-1840.
13. Söderman P., Malchau H. Validity and reliability of Swedish WOMAC osteoarthritis index: A self-administered disease-specific questionnaire (WOMAC) versus generic instruments (SF-36 and NHP). Acta Orthopaedica Scand 2000, 71:39-46.
14. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. McConnell, Kolopack, Davis. Arthritis Care & Research, 2001; 45:453-61.
15. Hurst N.P., Kind P., Ruta P.A., Hunter M., Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQoL (EQ-5D). Brit J Rheumatol 1997, 36:551-559.
16. Breivik E.K., Barkvoll P., Skovlund E. Combining diclofenac with acetaminophen or acetaminophen-codeine after oral surgery: a randomized, double-blind single-dose study. Clin Pharmacol Thr 1999, 66:625-635.
17. Ong C.K.S., Seymour R.A., Lirk P., Merry A.F. Combining paracetamol (acetaminophen) with nonstroidal antiinflammatory drugs: A qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg 2010, 110:1170-1179.
18. Stubhaug A., Breivik H. Clinical trials: Acute and chronic pain. Clinical Management of Pain - Practice and Procedures 2008, 514-528. Hodder-Arnold, London. 2nd ed. H. Breivik, W. Campbell, M. Nicholas (Eds.).
19. Hals E.K.B. Clinical trials: Dental pain. Clinical Management of Pain - Practice and Procedures 2008, 529-537. Hodder-Arnold, London. 2nd ed. H. Breivik, W. Campbell, M. Nicholas (Eds.).
20. Watkins P.B., Kaplowitz N., Slattery J.T., Colonese C.R., Colucci S.V., Stewart P.W., Harris S.C. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA. 2006, 296:87-93.
21. Kaasa T., Romundstad L., Breivik H. New therapeutic principles for adverse effects on upper and lower gastrointestinal tract in patients treated with opioid analgesics. Scand J Pain 2009, Supple 1:S12-S17.
22. Breivik H., Borchgrevink P.C., Allen S.M., Rosseland L.A., Romundstad L., Hals E.K., Kvarstein G., Stubhaug A. Assessment of pain. Br J Anaesth 2008, 101:17-24.
23. Allen KD, Coffman CJ, Golightly YM, Stechuchak KM, Voils CI, Keefe FJ. Comparison of pain measures among patients with osteoarthritis. J Pain. 2009 (in press- available online at April 20, 2010). http://www.sciencedirect.com/.
24. Kidd B.L., Langford R.M., Wodehouse T. Arthritis and pain. Current approaches in the treatment of arthritic pain. Arthritis Res Ther. 2007, 9:214-227.
25. Dworkin R.H., O'Connor A.B., Backonja M., Farrar J.T., Finnerup N.B., Jensen T.S., Kalso E.A., Loeser J.D., Miaskowski C., Nurmikko T.J., Portenoy R.K., Rice A.S., Stacey B.R., Treede R.D., Turk D.C., Wallace M.S. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007, 132:237-251.
26. Skurtveit S., Furu K., Kaasa S., Borchgrevink P.C. Introduction of low dose transdermal buprenorphine -- did it influence use of potentially addictive drugs in chronic non-malignant pain patients?. Eur J Pain. 2009, 13:949-953.
27. Pergolizzi J, Aloisi AM, Dahan A, Filitz J, Langford R, Likar R, Mercadante S, Morloin B, Raffa RB, Sabatowski R, Sacerdote P, Torres LM, Weinbroum AA. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract 2010 (Epub ahead of print. PMID: 20492579. ). doi:10.1111/j.15333-2500.2010.00378.x.